Acyclovir Sodium (AuroMedics Pharma LLC)
Welcome to the PulseAid listing for the Acyclovir Sodium drug offered from AuroMedics Pharma LLC. This DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AuroMedics Pharma LLC |
NON-PROPRIETARY NAME: | Acyclovir Sodium |
SUBSTANCE NAME: | ACYCLOVIR SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-10-11 |
END MARKETING DATE: | 0000-00-00 |
Acyclovir Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Acyclovir Sodium from AuroMedics Pharma LLC |
LABELER NAME: | AuroMedics Pharma LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/10mL) |
START MARKETING DATE: | 2013-10-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55150-154_370af699-a098-4574-958e-1f6d5b60866c |
PRODUCT NDC: | 55150-154 |
APPLICATION NUMBER: | ANDA203701 |
Other ACYCLOVIR SODIUM Pharmaceutical Manufacturers / Labelers: